Rafael Holdings RFL
NYSE RFL
$1.29 +0.01 (+1.17%)
As of: Oct 23, 2026 · 2:56 PM EDT

Rafael Holdings (RFL) Amortization of Deferred Charges (2019 - 2025)

Updated

Analysis

Rafael Holdings (RFL) Amortization of Deferred Charges (2019 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,129.65 Bn 1,098.23 Bn 19.71 Bn
2 Johnson & Johnson 635.30 Bn 555.16 Bn 17.30 Bn
3 AbbVie 504.45 Bn 477.56 Bn 12.70 Bn
4 Merck 358.32 Bn 312.70 Bn 12.21 Bn
5 Novartis Ag 290.03 Bn 254.02 Bn 11.24 Bn
6 Astrazeneca 265.08 Bn 238.77 Bn 12.86 Bn
7 Amgen 237.81 Bn 193.21 Bn 7.24 Bn
8 Gilead Sciences 194.88 Bn 169.07 Bn 6.22 Bn
9 Pfizer 171.37 Bn 118.01 Bn 10.94 Bn
10 Rafael Holdings 66.34 Mn -100.27 Mn 163,000.00
Historic Data

Historic Data

Download Data
DateValue
Jan 31, 2025 -28,000.00
Oct 31, 2024 -257,000.00
Jul 31, 2024 -393,000.00
Apr 30, 2024 -446,000.00
Jan 31, 2024 -533,000.00
Oct 31, 2023 -519,000.00
Apr 30, 2022 125,000.00
Jan 31, 2022 125,000.00
Oct 31, 2021 125,000.00
Oct 31, 2019 54,000.00
Jul 31, 2019 6,000.00
Apr 30, 2019 6,000.00
API Access

Rafael Holdings Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=RFL&period=max&api_key=YOUR_API_KEY